Article Text

Download PDFPDF
Oral Ivermectin is more effective than topical malathion in difficult-to-treat head lice infestation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Sources of funding The manufacturer of Ivermectin (Johnson & Johnson–Merck Sharp & Dohme-Chibret) funded the trial, was involved in the study design and provided the study medications. A ‘contract research organisation’ collected the data. An industry author was involved in the writing of the manuscript. All but one author received consulting fees from the manufacturer, held stock options in the company or were employed by the manufacturer.

Footnotes

  • Competing interests None.

  • Provenance and peer review Commissioned, internally peer reviewed.